Delivery Order SPE2DB22D3102-SPE2DB25FL2AA

Award Date 6/27/25
Potential Completion Date 6/30/25
Potential Value $1.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,308.80 Firm Fixed Price delivery order contract is for the supply of OCELLA 3 MG-0.03 MG TABLET 28S, a pharmaceutical product. The contract has an Ultimate Completion Date of August 14, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The $1,953.38 firm fixed-price contract is for the supply of 4565483040 Ocella 3 mg-0.03 mg tablet 28s, a prescription pharmaceutical product. The contract has an ultimate completion date of August 19, 2024. AmerisourceBergen is a major supplier of pharmaceutical and medical products to the U.S. federal government, including military treatment facilities and...
This federal contract award, valued at $1,882.72, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order (DO) for the supply of OCELLA 3 MG-0.03 MG TABLET 28S, a pharmaceutical product. The contract has an ultimate completion date of April 13, 2023 and is a Firm Fixed Price (FFP) contract. The contract was not designated with any set-aside requirements, indicating open...
This federal contract award, issued by the Defense Logistics Agency (DLA), is a $2,078.57 firm-fixed-price delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of OCELLA 3 MG-0.03 MG TABLET 28S, a pharmaceutical product, with a period of performance through July 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, serving...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $3,773.29 firm-fixed-price delivery order contract is for the provision of the pharmaceutical product "OCELLA 3 MG-0.03 MG TABLET 28S". The contract has an ultimate completion date of January 5, 2022 and does not utilize any set-aside designations, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $4,148.02 Firm Fixed Price Delivery Order contract is for the supply of OCELLA 3 MG-0.03 MG TABLET 28S, a pharmaceutical product. The contract has an ultimate completion date of May 3, 2024 and was awarded on May 2, 2024. It is not designated as a set-aside contract. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds...
This federal contract award, identified as SPE2DB20D1100|SPE2DB25FB7A2, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,185.36 firm fixed-price delivery order is for the supply of Ocella 3 mg-0.03 mg tablets, a pharmaceutical product. The contract has an ultimate completion date of April 15, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. The $1,534.18 firm fixed-price delivery order is for the pharmaceutical product OCELLA 3 MG-0.03 MG TABLET 28S. This award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract has no...
This federal contract award, valued at $2,338.94, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of OCELLA 3 MG-0.03 MG tablets, a pharmaceutical product. The award is a delivery order under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00. This IDC serves as the primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,799.50 firm fixed-price delivery order is for the supply of OCELLA 3 MG-0.03 MG TABLET 28S, a pharmaceutical product. The award is a task order under Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to...
  • SPE2DB22D3102
    Indefinite Delivery Contract
  • SPE2DB22D3102-SPE2DB25FL2AA
    Delivery Order

This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,114.94 firm fixed-price contract is for the delivery of OCELLA 3 MG-0.03 MG TABLET 28S, a prescription medication. The contract has an ultimate completion date of June 30, 2025 and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This prime contract allows for multiple delivery orders across different therapeutic categories, positioning Amerisourcebergen as a critical vendor in supporting federal medical procurement needs, particularly for military and veteran healthcare systems.

Generated 9/26/25, 10:02 AM